Interventional procedures versus medical therapy alone: outcome of cardiac patient management - a systematic review
Related Experiment Video
Updated: Dec 28, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Ahmed Abuosa1, Ayman Elshiekh1, Abdulhalim J Kinsara2
1Ministry of National Guard Health Affair, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.
Insights
Interventions benefit ST-segment-elevation myocardial infarction (STEMI) patients, while medication improves survival for heart failure and hypertension. Not all cardiac interventions offer survival advantages.
Area of Science:
- Cardiology
- Clinical Medicine
- Evidence-Based Practice
Background:
- Cardiac patients require management via medication or intervention.
- The comparative survival benefits of these approaches are crucial for clinical decision-making.
Purpose of the Study:
- To review current evidence on the survival benefits of medical management versus interventional procedures in various cardiac conditions.
- To identify which cardiac patient populations benefit most from specific treatment strategies.
Main Methods:
- Systematic review of recent clinical trials and guidelines.
- Analysis of survival data for patients with ST-segment-elevation myocardial infarction (STEMI), chronic stable coronary artery disease, heart failure, valve disease, atrial fibrillation, hypertension, and dyslipidemia.
Main Results:
- Primary cardiac intervention improves survival in STEMI patients.
- Medical therapy demonstrates survival benefits in heart failure, hypertension, and dyslipidemia (when target goals are met).
- Interventions showed no mortality benefit in chronic stable coronary artery disease or atrial fibrillation (CABANA trial). Mild/moderate valve disease does not necessitate intervention.
Conclusions:
- Medical therapy offers significant survival benefits for numerous cardiac conditions.
- Interventional procedures are not universally superior and should be selectively applied based on evidence.
- Tailoring treatment strategies to specific cardiac diagnoses is essential for maximizing patient survival.
Abstract:
Cardiac patients are managed medically or with an intervention. This review aimed to explore the survival benefit of each approach in the management of cardiac patients. We reviewed updated evidence of survival benefit from the most recent trials and guidelines. Patients with ST-segment-elevation myocardial infarction (STEMI) have a mortality benefit when a primary cardiac intervention is implemented. No similar benefit has been shown in chronic stable coronary artery disease. Heart failure patients show a mortality benefit using medication and similarly, mild or moderate valve disease patients do not require an intervention. In atrial fibrillation, the CABANA trial using ablation therapy, had no mortality benefit. Hypertension drug therapy showed a significant mortality benefit, a similar benefit was noted with drug therapy for the treatment of dyslipidemia, when achieving the target lipid goal. Not all interventional procedures result in a mortality benefit. Medical therapy alone increases survival in many cardiac diseases.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Mitral Stenosis III: Medical Management
Angina IV: Management
Heart Failure VI: Adjunct Therapies

